Entheon Biomedical Corp.
ENTBF
$0.069
-$0.0114-14.18%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 0.00 | 0.00 |
| SG&A Expenses | 264.40K | 290.40K | 244.10K | 236.80K | 260.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 264.40K | 290.40K | 244.10K | 236.80K | 260.10K |
| Operating Income | -264.40K | -290.40K | -244.10K | -236.80K | -260.10K |
| Income Before Tax | -257.10K | -279.20K | -233.20K | -226.20K | -250.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.26 | -0.28 | -0.23 | -0.23 | -0.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -257.10K | -279.20K | -233.20K | -226.20K | -250.20K |
| EBIT | -264.40K | -290.40K | -244.10K | -236.80K | -260.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 43.59M | 37.06M | 30.94M | 28.00M | 25.05M |
| Average Diluted Shares Outstanding | 43.59M | 37.06M | 30.94M | 28.00M | 25.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |